Treatment Of Steroid-Refractory Acute GVHD With Mesenchymal Stem Cells Improves Outcomes In Pediatric Patients; Results Of The Pediatric Subset In A Phase III Randomized, Placebo-Controlled Study
Paul Szabolcs(Children's Hospital of Pittsburgh), Joanne Kurtzberg(Duke University), Giuseppe Visani(Ospedali Riuniti Marche Nord), Gary Kleiner(University of Miami), Julie‐An Talano(Dana-Farber Cancer Institute), Eneida R. Nemecek(Oregon Health & Science University), Franco Locatelli(Bambino Gesù Children's Hospital)
Cited by 28
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577